Physician

Carter Louis Capra, M.D.

According to 2025 Medicare claims, Carter Capra, M.D. (NPI: 1033559430) practices hematology/oncology in the Birmingham, AL market, with the plurality of this provider's patient population coming from Jefferson, AL. This provider's primary affiliated billing organization is BIRMINGHAM HEMATOLOGY ONCOLOGY ASSOC LLC (NPI: 1841216389; TIN: 522170293) and primary practice location at 35205-1202.

Capra's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 306 traditional Medicare patients, billed 156,585 HCPCS/CPT codes, and received $3,769,546 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,819 prescription claims across 240 beneficiaries totaling $4,719,165 in drug costs, led by Revlimid (Lenalidomide). DME data shows 96 claims. Open Payments data shows 173 records totaling $10,264. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $261,220 to $3,769,546. Similarly, Part D prescription costs have risen steadily, from $6,965 to $4,719,165. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	128	21,557	$261,220
2020	208	39,683	$721,313
2021	404	106,108	$1,473,063
2022	379	162,479	$2,653,924
2023	370	156,102	$2,663,463
2024	306	156,585	$3,769,546

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	21	155	$6,965
2016	47	282	$18,139
2017	51	147	$7,399
2018	53	165	$34,397
2019	68	211	$34,629
2020	89	456	$672,721
2021	154	829	$1,851,140
2022	234	1,699	$4,933,372
2023	264	1,864	$4,567,324
2024	240	1,819	$4,719,165

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	38	$2,964
2022	N/R	67	$1,908
2023	N/R	66	$10,349
2024	N/R	96	$5,534

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	59	96	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	180	713	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	109	142	$53
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	193	386	$12
36415	Insertion of needle into vein for collection of blood sample	252	813	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	72	2,002	$1,237,624
Ibrance	Palbociclib	46	1,288	$712,631
Lenalidomide	Lenalidomide	50	1,323	$578,256
Tagrisso	Osimertinib Mesylate	22	660	$370,007
Piqray	Alpelisib	17	476	$361,936

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	N/R	11	$1,605
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$1,026
E0656	Segmental pneumatic appliance for use with pneumatic compressor, trunk	Y	N/R	14	$742
E0657	Segmental pneumatic appliance for use with pneumatic compressor, chest	Y	N/R	14	$697
J8521	Capecitabine, oral, 500 mg	N	N/R	15	$692

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	172	$3,582	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$6,683	E.R. Squibb & Sons, L.L.C.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Carter Louis Capra, M.D.?

Tedicare shows public-source Medicare data for Carter Louis Capra, M.D. (NPI 1033559430), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carter Louis Capra, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Carter Louis Capra, M.D.?

Carter Louis Capra, M.D. is linked to BIRMINGHAM HEMATOLOGY ONCOLOGY ASSOC LLC (billing NPI 1841216389) in the available physician profile data.

Does Carter Louis Capra, M.D. have Open Payments data?

Carter Louis Capra, M.D. has 173 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.